NYU Grossman School of Medicine Gynecologic Oncology

Topics

• Endometrial and Cervical Cancer Treatments 175
• Ovarian cancer diagnosis and treatment 79
• PARP inhibition in cancer therapy 31
• Cervical Cancer and HPV Research 29
• Uterine Myomas and Treatments 21
• BRCA gene mutations in cancer 16
• Gestational Trophoblastic Disease Studies 15
• COVID-19 and healthcare impacts 11
• Maternal and fetal healthcare 11
• Genetic factors in colorectal cancer 10
• Cancer survivorship and care 9
• Palliative Care and End-of-Life Issues 9

Most cited

1. Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.

   The New England journal of medicine · 2023 · 703 citations · Bhavana Pothuri

2. Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.

   The New England journal of medicine · 2023 · 633 citations · Joanie Hope, Fernanda Musa

3. Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

   Annals of oncology : official journal of the European Society for Medical Oncology · 2023 · 360 citations · Bhavana Pothuri

4. Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial.

   Annals of oncology : official journal of the European Society for Medical Oncology · 2024 · 148 citations · Bhavana Pothuri

5. Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET-a phase I, single-arm study.

   Journal for immunotherapy of cancer · 2022 · 271 citations · Bhavana Pothuri